Insider buying last 90 days
No open-market insider purchases were filed for WAY in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every WAY insider filing, plotted on the chart in Gekko.Open WAY in Gekko
NASDAQ: WAY
Waystar (WAY) Stock Analysis & Forecast
Sep 28 close
$25.74+1.04 (+4.2%)
Gekko Brief
AI summaryWaystar's stock drew attention this week from a client success story, with AnMed recovering $6.32 million using the company's revenue management offerings, underscoring the platform's commercial traction. Analyst sentiment also featured, with a consensus "Moderate Buy" rating and a price target near $34.67 cited alongside the news. A stockholder investigation announcement from Kaskela Law Firm also circulated, examining potential securities law or fiduciary duty issues, while several director RSU grant corrections and an institutional stake reduction by Corient Private Wealth LP appeared in filings during the period.
Shares closed at $25.74, up 4.2%, sitting between the 50-day average of $24.33 and the 200-day average of $24.51, reflecting a mixed short-term trend. The GekkoIndex reads 56.7, placing Waystar in the Neutral zone. Price remains 42% below Gekko Fair Value of $44.39, a gap that stands out against the recent trading range between $17.26 and $40.35 over the past year.
Waystar's next earnings report is scheduled for 4 November 2026 after the close, 36 days out and beyond a typical 20-trading-day holding window. The prior quarter saw an EPS beat of $0.37 versus a $0.35 estimate, though shares reacted with an 11.6% move. Analyst coverage remains heavily weighted toward buy ratings, with 16 of 18 firms in that camp. No insider, Congress, or unusual options activity appears in the current window, leaving smart-money signals quiet for now.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Waystar price vs fair value
Close $25.74200-day averageGekko Fair Value $44.39
Waystar quick facts
- Market cap
- $4.94B
- P/E ratio
- 35.2
- Forward P/E
- 12.8
- EPS, TTM
- $0.70
- Revenue, TTM
- $1.21B
- Profit margin
- 11.2%
- Dividend yield
- —
- Beta
- 0.15
- Volume
- 1.93M avg 2.03M
- 1-year return
- −30.6%
- Typical daily move
- ±4.3%
- Typical 20-day move
- ±6.9%
- 50-day average
- $24.33
- 200-day average
- $24.51
- Next earnings
- Nov 4 after close
- Shares outstanding
- 191.7M
Waystar swing-trade checklist
Waystar scores 2 supportive, 2 mixed and 0 headwinds across the 4 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive2 mixed0 headwinds
- Trendmixed
Averages disagree
Close $25.74 sits between the 50-day ($24.33) and 200-day ($24.51) averages, or the averages disagree.
See the chart - GekkoIndexmixed
56.7, Neutral
Reading 56.7 is in the Neutral zone.
See the GekkoIndex - Fair valuesupportive
42.0% below
Price is 42% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 36 days
Next report Nov 4, 2026, 36 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalityno data
No data
Not enough years of history for a seasonal read.
A description of current data, not a recommendation. How this page works
Waystar stock chart and price history
Waystar closed at $25.74 on Sep 28, 2026, −30.6% over the past year, inside a 52-week range of $17.26 to $40.35.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +1.9%
- 3 months
- +28.8%
- 6 months
- +9.3%
- 1 year
- −30.6%
The full WAY chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open WAY in Gekko
Follow Waystar through every session
Put WAY on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track WAY in GekkoFree for 7 days. No credit card required.
About Waystar
Waystar develops a cloud-based software platform aimed at simplifying the financial transactions that run through the healthcare industry. The platform brings together several functions in one system, including pre-approving finances, helping patients manage their billing, and overseeing the handling of claims and payments. It also works to prevent denied claims and recover them when they occur, supports efforts to capture more revenue, and produces analytics and reporting that give users visibility into these financial processes.
The company's offerings are built around this connected set of tools rather than a single standalone product, tying together the different stages of healthcare-related financial activity. Its customer base is concentrated among organizations that operate within the healthcare sector, relying on the platform to manage these transactions.
Waystar was founded in 2017 and is based in Lehi, Utah. The company's shares trade on the NASDAQ exchange under the ticker symbol WAY.
- Listed
- NASDAQ
- Sector
- Technology services
- Industry
- Packaged software
- Website
- waystar.com
Waystar GekkoIndex: the smart money zone
Waystar’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 56.7, in the Neutral zone, up 1.1 points over five sessions.
56.7Neutral
Up 1.1 points over five sessions.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 26 | +0.5% | +4.4% | ||
| Accumulation | 195 | +0.7% | −1.4% | ||
| Neutral (current zone) | 311 | +0.2% | +2.6% | ||
| Distribution | 38 | −0.4% | 0.0% | ||
| Selling | 2 | Too few readings yet | |||
Average WAY share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the WAY price, zone by zone.Track WAY in Gekko
Is Waystar stock overvalued? Gekko Fair Value
Waystar trades 42.0% below Gekko Fair Value of $44.39, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Waystar shares are worth, recalculated every trading day.
$44.39
Gekko Fair Value, Sep 26, 2026
42.0% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open WAY in Gekko
Waystar insider and Congress trading
No open-market insider purchases were filed for Waystar, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in WAY were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for WAY, plotted on the chart in Gekko.Open WAY in Gekko
Buybacks
Waystar has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $12.74M
- As a share of market cap
- 0.26%
From company filings.
Hedge funds and billionaires quarter ended Jun 30
2of the funds Gekko tracks hold WAY.
1added1opened0trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko
Waystar earnings: next date and track record
Waystar reports on Nov 4, 2026, after the close (36 days away), and beat the EPS estimate in 6 of its last 8 reports.
Next earnings report
Nov 4, 2026
Expected after the close, 36 days away
- EPS estimate
- $0.41
- Revenue estimate
- $323.3M
6 of 8reports beat the EPS estimate
±8.7%average move across the report
4 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Jul 29, 2026 AI summary
- What they said
- Waystar reported a strong Q2 2026 with revenue of $320M (18% YoY growth), adjusted EBITDA of $137M (43% margin), and solid bookings driven by larger platform deals and AI-enabled solutions. Management emphasized continued momentum in bookings, growth in high-value clients (clients >$100k revenue grew 15% YoY to 1,453), and 108% net revenue retention. Subscription revenue was a notable strength (55% of revenue, +34% YoY). Management highlighted the Iodine acquisition and AI capabilities as strategic drivers (pre-bill anomaly detection and clinical-financial integration), reported ~40% of bookings were AI-enabled, and increased capitalized software spend (roughly doubled year-over-year) to accelerate AI solutions. Management expressed confidence in the full-year outlook while reserving room to invest in AI and product development. The Q&A was constructive with management providing detailed, confident answers on volumes, NRR, compute costs, implementation timelines (6–18 months typical), and competitive positioning relative to EHR vendors.
- Guidance
- Full-year guidance maintained. Management reiterated confidence in the full-year revenue and adjusted EBITDA outlook, with an indicated full-year adjusted EBITDA margin target of ~42% (company delivered 43% in Q2). Bookings implementation lead times for large deals are generally 6–18 months. AI-enabled solutions represent roughly 40% of bookings. Capitalized software spend is expected to remain elevated for 2026 (first-half run rate indicative for remainder of year), with possible additional increases to accelerate AI development.
- Risks flagged
- Regulatory and macro uncertainty (changes in Medicaid/ACA affecting payer mix and patient volumes), seasonality and patient-utilization variability affecting volume-based revenue, increased capitalized software and compute costs as AI adoption scales, competitive pressure from large EHR vendors and point solutions, longer implementation timelines for large platform deals that can delay revenue realization.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 29, 2026 | $0.37 est $0.35 | $319.7M est $316.2M | −11.6% |
| Apr 29, 2026 | $0.42 est $0.39 | $313.9M est $311.7M | −15.3% |
| Feb 17, 2026 | $0.36 est $0.39 | $303.5M est $294.8M | +13.4% |
| Oct 29, 2025 | $0.37 est $0.34 | $268.7M est $294.7M | −6.2% |
| Jul 30, 2025 | $0.36 est $0.33 | $270.7M est $256.1M | +3.6% |
| Apr 30, 2025 | $0.32 est $0.32 | $256.4M est $254.0M | +6.6% |
| Feb 18, 2025 | $0.29 est $0.14 | $244.1M est $248.5M | −3.3% |
| Nov 6, 2024 | $0.14 est $0.11 | $240.1M est $232.3M | +9.2% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Waystar stock forecast and analyst price targets
Analysts’ average 12-month price target for Waystar is $33.43, +29.9% from the last close, from 18 firms rating the stock in the last 90 days.
$33.43consensus 12-month target, +29.9% from the last close
Now $25.74Avg $33.43
Low $28High $44
Each firm’s latest rating in the last 90 days: 18 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 16 | Morgan Stanley | $28 | +8.8% |
| Sep 16 | Canaccord Genuity | $33 | +28.2% |
| Sep 16 | Leerink Partners | $35 | +36.0% |
| Sep 16 | Truist Financial | — | — |
| Sep 15 | Bank of America Securities | $38 | +47.6% |
+2.6%average 20-day move after past Neutral readings
±4.3%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Waystar market cap and key statistics
Waystar’s market cap is $4.94B, with a P/E ratio of 35.2 and revenue of $1.21B over the last twelve months.
Valuation
- Market cap
- $4.94B
- P/E ratio
- 35.2
- Forward P/E
- 12.8
- EPS, TTM
- $0.70
- Gekko Fair Value
- $44.39
Trading
- Volume
- 1.93M
- Avg volume, 20 days
- 2.03M
- 52-week high
- $40.35
- 52-week low
- $17.26
- Shares outstanding
- 191.7M
Financials
- Revenue, TTM
- $1.21B
- Profit margin
- 11.2%
- Return on equity
- 3.8%
- Quarterly earnings growth, YoY
- +16.7%
Risk and income
- Beta
- 0.15
- Typical daily move
- ±4.3%
- Typical 20-day move
- ±6.9%
Waystar stock news this week
Coverage of Waystar this week reads neutral: 2 positive, 6 neutral and 1 negative headlines.
- Waystar Holding Corp. $WAY Stock Sold by Corient Private Wealth LPMarketBeat, Sep 27
- Form 4 Waystar Holding Corp For: 26 September By Investing.comInvesting.com Australia, Sep 26
- Waystar Director Priscilla Hung Updates RSU Grant Details in Amended FilingKalkine Media, Sep 25
- A corrected award for Waystar (WAY) director Robert DeMichiei replaces 9,303 stock units with 10,446.Stock Titan, Sep 25
- After a corrected 10,446-unit grant, Waystar (WAY) director Vivian Riefberg reported a direct position of 24,275 shares.Stock Titan, Sep 25
- Waystar (WAY) chairperson holds 101,203 shares after a corrected stock grant.Stock Titan, Sep 25
Waystar peers
Waystar’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MSFTMicrosoft | Neutral | 17.3% above |
| PLTRPalantir Technologies | Neutral | 15.7% above |
| ORCLOracle | Accumulation | 25.9% below |
| PANWPalo Alto Networks | Neutral | 16.1% above |
| CRWDCrowdStrike | Neutral | 27.2% above |
| CRMSalesforce | Neutral | 5.9% below |
A peer links to its own page where one exists.
Waystar stock FAQ
What is Waystar’s market cap?
Waystar’s market cap is $4.94B at the Sep 28, 2026 close of $25.74, with 191.7M shares outstanding. The shares trade on a P/E ratio of 35.2.
What is the Waystar stock forecast?
The consensus analyst 12-month price target for Waystar is $33.43, +29.9% from the last close. Of the 18 firms that rated the stock in the last 90 days, 16 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Waystar stock overvalued or undervalued?
On Gekko’s estimate Waystar is undervalued: the Sep 28, 2026 close of $25.74 is 42.0% below Gekko Fair Value of $44.39. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Waystar report earnings next?
Waystar is expected to report on Nov 4, 2026, after the market closes (36 days away). Analysts expect earnings of $0.41 per share on revenue of $323.3M. Waystar beat the earnings estimate in 6 of its last 8 reports, moving 8.7% on average across the report.
What is Waystar’s 52-week high and low?
Waystar’s 52-week high is $40.35 and its 52-week low is $17.26; it closed at $25.74 on Sep 28, 2026, −30.6% over the past year. Over the last five years the shares peaked at $48.11 on Feb 18, 2025.
Is Waystar stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 4 items with data read as supportive (fair value and earnings risk), 2 as mixed (trend and gekkoindex). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Waystar the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.